Health Care/Hospital

University Of Maryland Patient Exceeding Expectations Seven Months After Most Extensive Face Transplant Ever Performed

-- Richard Lee Norris returning to normal life after 15 years as recluse BALTIMORE, Oct. 17, 2012 /PRNewswire/ -- The University of Maryland released details today on the recovery of Richard Lee Norris, the 37-year-old man who received the most extensive full face transplant completed to date sev...

2012-10-17 08:21 942

Mindray to Report Third Quarter 2012 Financial Results on November 5, 2012

SHENZHEN, China, Oct. 16, 2012 /PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the third quarter ended September 30, 2012 after the U....

2012-10-16 20:00 778

Frost & Sullivan Customer Value Enhancement Award Recognizes GE Healthcare's AgileTrac

RTL S technology -based AgileTrac supports total visibility of hospital assets and resources, resulting in optimum capacity utilization and workflows MOUNTAIN VIEW, Calif., Oct. 16, 2012 /PRNewswire/ -- Frost & Sullivan recently analyzed real-time location system (RTLS) solutions for the hospital...

2012-10-16 20:00 1101

Frost & Sullivan: Past the Intricacies, Participants Discover a Wealth of Opportunities in the North American Telehealth Industry

The convergence between healthcare, information and communication technologies MOUNTAIN VIEW, Calif., Oct. 16, 2012 /PRNewswire/ -- The continuing alignment of healthcare with information and communication technologies makes the telehealth (which also includes remote patient monitoring( http://bi...

2012-10-16 19:45 803

New Research Reveals a Significant Proportion of Bipolar I Disorder Patients Experience Depressive Symptoms During Mania

VIENNA, Oct. 16, 2012 /PRNewswire/ -- The Investigating Manic Phases And Current Trends in Bipolar (IMPACT) study, which was designed to investigate the effects of periods of mania in people diagnosed with bipolar I disorder, also found for over three-quarters of respondents,bipolar I disorder ha...

2012-10-16 19:30 958

Assisted Reproduction: New Technology Offers Improved Chances for Couples Undergoing IVF

AARHUS, Denmark, Oct. 16, 2012 /PRNewswire/ -- The success rate of assisted reproduction may be significantly increased by the use of revolutionary new technology A study accepted for publication in the renowned scientific journal Fertility & Sterility, shows that a revolutionary and clinicall...

2012-10-16 15:00 1431

Revascularization with OrbusNeich's Genous(TM) Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

British Medical Journal (BMJ) Case Report Features Patient with Immune Thrombocytopenic Purpura HONG KONG, Oct. 16, 2012 /PRNewswire/ -- OrbusNeich today announced the publication of a case report demonstrating that revascularization with the Genous Stent may enable the safe and early discontinua...

2012-10-16 10:39 1669

WuXi PharmaTech Schedules Third-Quarter 2012 Earnings Release

SHANGHAI, Oct. 15, 2012 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 201...

2012-10-16 00:35 784

ChanTest Announces Drug Discovery Services Using the Enamine 3D Compound Library

CLEVELAND, Oct. 15, 2012 /PRNewswire/ -- ChanTest, the industry leading ion channel Contract Research Organization (CRO) announces today the addition of a 50,000 compound chemical library from Enamine Ltd., a leading provider of screening compounds and chemical building blocks. This compound library...

2012-10-15 20:00 1489

Cheng Ching General Hospital Delivers First TrueBeam STx Radiosurgery Treatments in Taiwan

Liver cancer patients among the first to receive treatment using fast, precise new system optimized for radiosurgery TAICHUNG, Oct. 15, 2012 /PRNewswire/ -- Doctors at the Cheng Ching General Hospital here have begun treating liver cancer with image-guided radiosurgery using a new TrueBeam(TM) ST...

2012-10-15 20:00 1558

A New Post Hoc Analysis Indicates asenapine has Effect on Both Manic and Depressive Symptoms in Bipolar I Disorder Patients Experiencing Mixed Episodes

ECNP, VIENNA, Oct. 15, 2012 /PRNewswire/ -- Post hoc analyses presented at the 25th European College of Neuropsychopharmacology (ECNP) congress show asenapine achieves significant control of mixed episodes in bipolar I disorder compared to placebo. - For media outside China, Japan, UK, USA onl...

2012-10-15 19:30 2539

Frost & Sullivan Company of the Year Award in Medical Grade PCs Presented to Advantech

Excellence in Growth Strategy and Implementation Underpin Company's Strong Performance LONDON, Oct. 15, 2012 /PRNewswire/ -- Based on its recent analysis of the medical grade PCs market, Frost & Sullivan recognises Advantech Co., Ltd. with the prestigious 2012 European Company of the Year Award. ...

2012-10-15 19:28 822

Biostar Pharmaceuticals, Inc. Signs a $3 million Agreement to Manufacture and Supply Xijing Military Hospital with Five Additional Drugs

XIANYANG, China, Oct. 15, 2012 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that on October 8, 20...

2012-10-15 19:00 1132

Helsinn Grants Specialised Therapeutics Australia (STA) Rights to Anamorelin, a First-in-Class Compound to Treat Cachexia-Anorexia Related to Non-Small Cell Lung Cancer (NSCLC)

LUGANO, Switzerland and MELBOURNE, Australia, Oct. 15, 2012 /PRNewswire/ -- Melbourne biopharmaceutical company Specialised Therapeutics Australia (STA) has been granted exclusive commercialisation rights to a new drug for the treatment of NSCLC cachexia-anorexia. This condition is a serious multifa...

2012-10-15 14:21 935

IASP Sponsors Global Year Against Visceral Pain

Initiative promotes better visceral pain management through increased awareness SEATTLE, Oct. 15, 2012 /PRNewswire/ -- The Global Year Against Visceral Pain launches today, bringing global attention to pain that originates in or near the internal organs of the body. Visceral pain is the most freq...

2012-10-15 12:01 1055

3SBio Inc. Announces Results Of 2012 Annual General Meeting

SHENYANG, China, Oct. 13, 2012 /PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the results of shareholder votes at its Annual Gene...

2012-10-13 12:15 1021

VIP Cocktail Reception With the Pharmaceutical Society of Sri Lanka and CPhI

MUMBAI, India, Oct. 12, 2012/PRNewswire/ -- The world's largest pharmaceutical organiser CPhI, in collaboration with the Pharmaceutical Society of Sri Lanka, is pleased to cordially invite you to an exclusive VIP cocktail reception. Date: Wednesday, 17 October 2012 Time: 5:00 pm Venue: H...

2012-10-12 17:48 905

Simcere Pharmaceutical Group Announces Resignation of an Independent Director

NANJING, China, Oct. 12, 2012 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced the resignation of ...

2012-10-12 17:47 716

CROMSOURCE Acquires PDR Partners - Expands UK Staffing Solutions Services

VERONA, Italy, Oct. 12, 2012 /PRNewswire/ -- CROMSOURCE, an international, full-service contract research organization (CRO) today announced the acquisition of PDR Partners Ltd, an established staffing and recruitment organization with offices in Bracknell, UK. PDR Partners was launched in 2002, ...

2012-10-12 15:00 1451

New Disposable Pen Injector Offers Ease of Use as well as Customization Options for Use with a Wide Range of Injectable Drugs

BD Introduces BD Vystra (TM) Disposable Pen at the 2012 Parenteral Drug Association Meeting in Las Vegas FRANKLIN LAKES, N.J., Oct. 12, 2012 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that the BD Vystra(TM) Disposable Pen will be showc...

2012-10-12 06:40 2216